About this Journal Submit a Manuscript Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2012 (2012), Article ID 461989, 15 pages
http://dx.doi.org/10.1155/2012/461989
Research Article

Mixture of Polyphenols and Anthocyanins from Vaccinium uliginosum L. Alleviates DNCB-Induced Atopic Dermatitis in NC/Nga Mice

Department of Preventive Pharmacy and Toxicology, College of Pharmacy, Kyung Hee University, 1 Hoegi, Seoul 130-701, Republic of Korea

Received 15 June 2012; Accepted 22 August 2012

Academic Editor: José Luis Ríos

Copyright © 2012 Min Ju Kim and Se-Young Choung. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Y. M. Leung and N. A. Soter, “Cellular and immunologic mechanisms in atopic dermatitis,” Journal of the American Academy of Dermatology, vol. 44, no. 1, pp. S1–S12, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. E. Guttman-Yassky, M. A. Lowes, J. Fuentes-Duculan et al., “Low expression of the IL-23/Th17 pathway in atopic dermatitis compared to psoriasis,” The Journal of Immunology, vol. 181, no. 10, pp. 7420–7427, 2008. View at Scopus
  3. Y. H. Kim, C. Y. Bang, E. K. Won, J. P. Kim, and S. Y. Choung, “Antioxidant activities of Vaccinium uliginosum L. extract and its active components,” Journal of Medicinal Food, vol. 12, no. 4, pp. 885–892, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Y. Bae, S. S. Lim, S. J. Kim et al., “Bog blueberry anthocyanins alleviate photoaging in ultraviolet-B irradiation-induced human dermal fibroblasts,” Molecular Nutrition and Food Research, vol. 53, no. 6, pp. 726–738, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. G. S. Jensen, X. Wu, K. M. Patterson et al., “In vitro and in vivo antioxidant and anti-inflammatory capacities of an antioxidant-rich fruit and berry juice blend. Results of a pilot and randomized, double-blinded, placebo-controlled, crossover study,” Journal of Agricultural and Food Chemistry, vol. 56, no. 18, pp. 8326–8333, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Jin, et al., “Animal models of atopic dermatitis,” The Journal of Allergy and Clinical Immunology, vol. 111, no. 2, pp. 486–494, 2003.
  7. E. Galli, R. Cicconi, P. Rossi, A. Casati, E. Brunetti, and G. Mancino, “Atopic dermatitis: molecular mechanism, clinical aspects and new therapeutical approaches,” Current Molecular Medicine, vol. 3, no. 2, pp. 127–138, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. S. J. Lee, S. G. Oh, S. W. Seo et al., “Oral administration of Astragalus membranaceus inhibits the development of DNFB-induced dermatitis in NC/Nga mice,” Biological and Pharmaceutical Bulletin, vol. 30, no. 8, pp. 1468–1471, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Jin, R. He, M. Oyoshi, and R. S. Geha, “Animal models of atopic dermatitis,” Journal of Investigative Dermatology, vol. 129, no. 1, pp. 31–40, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Hattori, M. Nishikawa, K. Watcharanurak et al., “Sustained exogenous expression of therapeutic levels of IFN-γ ameliorates atopic dermatitis in NC/Nga mice via Th1 polarization,” The Journal of Immunology, vol. 184, no. 5, pp. 2729–2735, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Grassegger and R. Höpfl, “Significance of the cytokine interferon gamma in clinical dermatology,” Clinical and Experimental Dermatology, vol. 29, no. 6, pp. 584–588, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Toldi, A. Molvarec, B. Stenczer et al., “Peripheral Th1/Th2/Th17/regulatory T-cell balance in asthmatic pregnancy,” International Immunology, vol. 23, no. 11, pp. 669–677, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. A. D. Cesare, P. D. Meglio, and F. O. Nestle, “A role for Th17 cells in the immunopathogenesis of atopic dermatitis?” Journal of Investigative Dermatology, vol. 128, no. 11, pp. 2569–2571, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. V. S. Beltrani, “Suggestions regarding a more appropriate understanding of atopic dermatitis,” Current Opinion in Allergy and Clinical Immunology, vol. 5, no. 5, pp. 413–418, 2005. View at Scopus
  15. D. Rudikoff and M. Lebwohl, “Atopic dermatitis,” The Lancet, vol. 351, no. 9117, pp. 1715–1721, 1998. View at Publisher · View at Google Scholar · View at Scopus
  16. T. B. Donald and Y. M. Leung, Atopic Dermatitis, Marcel Dekker, 2002.
  17. M. Furue, H. Terao, W. Rikihisa et al., “Clinical dose and adverse effects of topical steroids in daily management of atopic dermatitis,” British Journal of Dermatology, vol. 148, no. 1, pp. 128–133, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Valtueña, D. Del Rio, N. Pellegrini et al., “The total antioxidant capacity of the diet is an independent predictor of plasma β-carotene,” European Journal of Clinical Nutrition, vol. 61, no. 1, pp. 69–76, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Y. Wang and H. S. Lin, “Antioxidant activity in fruits and leaves of blackberry, raspberry, and strawberry varies with cultivar and developmental stage,” Journal of Agricultural and Food Chemistry, vol. 48, no. 2, pp. 140–146, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. T. M. Collantes, M.-C. Rho, H.-J. Kwon et al., “Azuki bean (Vigna angularis) extract inhibits the development of experimentally induced atopic dermatitis-like skin lesions in NC/Nga mice,” Food Chemistry, vol. 132, no. 3, pp. 1269–1275, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. H. S. Lee, S. K. Kim, J. B. Han et al., “Inhibitory effects of Rumex japonicus Houtt. on the development of atopic dermatitis-like skin lesions in NC/Nga mice,” British Journal of Dermatology, vol. 155, no. 1, pp. 33–38, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Inoue, M. Sugimoto, T. Sakurai et al., “Modulation of scratching behavior by silencing an endogenous cyclooxygenase-1 gene in the skin through the administration of siRNA,” Journal of Gene Medicine, vol. 9, no. 11, pp. 994–1001, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Maekawa, T. Yamaguchi-Miyamoto, H. Nojima, and Y. Kuraishi, “Effects of naltrexone on spontaneous itch-associated responses in NC mice with chronic dermatitis,” Japanese Journal of Pharmacology, vol. 90, no. 2, pp. 193–196, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Takano, I. Arai, and M. Kurachi, “Analysis of the spontaneous scratching behavior by NC/Nga mice: a possible approach to evaluate antipruritics for subjects with atopic dermatitis,” European Journal of Pharmacology, vol. 471, no. 3, pp. 223–228, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Park, J. B. Lee, and S. Kang, “Topical application of Chrysanthemum indicum L. Attenuates the development of atopic dermatitis-like skin lesions by suppressing serum IgE levels, IFN-γ , and IL-4 in Nc/Nga mice,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 821967, 8 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. H. C. Williams, “Epidemiology of atopic dermatitis,” Clinical and Experimental Dermatology, vol. 25, no. 7, pp. 522–529, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Flohr, “Atopic dermatitis diagnostic criteria and outcome measures for clinical trials: still a mess,” Journal of Investigative Dermatology, vol. 131, no. 3, pp. 557–559, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. J. H. Choi, B. H. Park, H. G. Kim et al., “Inhibitory effect of Psidium guajava water extract in the development of 2,4-dinitrochlorobenzene-induced atopic dermatitis in NC/Nga mice,” Food and Chemical Toxicology, vol. 50, no. 8, pp. 2923–2929, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. J. F. Fowler Jr., H. Woolery-Lloyd, H. Waldorf, and R. Saini, “Innovations in natural ingredients and their use in skin care,” Journal of Drugs in Dermatology, vol. 9, no. 6, pp. S72–S82, 2010. View at Scopus
  31. E. Middleton, C. Kandaswami, and T. C. Theoharides, “The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer,” Pharmacological Reviews, vol. 52, no. 4, pp. 673–751, 2000. View at Scopus
  32. C. A. Williams and R. J. Grayer, “Anthocyanins and other flavonoids,” Natural Product Reports, vol. 21, no. 4, pp. 539–573, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Suto, H. Matsuda, K. Mitsuishi et al., “NC/Nga mice: a mouse model for atopic dermatitis,” International Archives of Allergy and Immunology, vol. 120, supplement 1, pp. 70–75, 1999. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Yamamoto, T. Haruna, K. Yasui et al., “A novel atopic dermatitis model induced by topical application with Dermatophagoides farinae extract in NC/Nga mice,” Allergology International, vol. 56, no. 2, pp. 139–148, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. T. Kawakami, T. Ando, M. Kimura, B. S. Wilson, and Y. Kawakami, “Mast cells in atopic dermatitis,” Current Opinion in Immunology, vol. 21, no. 6, pp. 666–678, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. R. K. Kumar, C. Herbert, M. Yang, A. M. L. Koskinen, A. N. J. McKenzie, and P. S. Foster, “Role of interleukin-13 in eosinophil accumulation and airway remodelling in a mouse model of chronic asthma,” Clinical and Experimental Allergy, vol. 32, no. 7, pp. 1104–1111, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. I. Carmi-Levy, B. Homey, and V. Soumelis, “A modular view of cytokine networks in atopic dermatitis,” Clinical Reviews in Allergy and Immunology, vol. 41, no. 3, pp. 245–253, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. D. Y. M. Leung and T. Bieber, “Atopic dermatitis,” The Lancet, vol. 361, no. 9352, pp. 151–160, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Toda, D. Y. M. Leung, S. Molet et al., “Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions,” Journal of Allergy and Clinical Immunology, vol. 111, no. 4, pp. 875–881, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. T. Bieber, “Atopic dermatitis,” The New England Journal of Medicine, vol. 358, no. 14, pp. 1483–1430, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Grewe, K. Gyufko, E. Schopf, and J. Krutman, “Lesional expression of interferon-γ in atopic eczema,” The Lancet, vol. 343, no. 8888, pp. 25–26, 1994. View at Publisher · View at Google Scholar · View at Scopus
  42. T. Werfel, A. Morita, M. Grewe et al., “Allergen specificity of skin-infiltrating T cells is not restricted to a type-2 cytokine pattern in chronic skin lesions of atopic dermatitis,” Journal of Investigative Dermatology, vol. 107, no. 6, pp. 871–876, 1996. View at Scopus
  43. T. Thepen, E. G. Langeveld-Wildschut, I. C. Bihari et al., “Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial Th2 response to a Th1 response in situ: an immunocytochemical study,” Journal of Allergy and Clinical Immunology, vol. 97, no. 3, pp. 828–837, 1996. View at Publisher · View at Google Scholar · View at Scopus
  44. N. Novak, R. Valenta, B. Bohle et al., “FcεRI engagement of Langerhans cell-like dendritic cells and inflammatory dendritic epidermal cell-like dendritic cells induces chemotactic signals and different T-cell phenotypes in vitro,” Journal of Allergy and Clinical Immunology, vol. 113, no. 5, pp. 949–957, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. M. L. Giustizieri, F. Mascia, A. Frezzolini et al., “Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines,” Journal of Allergy and Clinical Immunology, vol. 107, no. 5, pp. 871–877, 2001. View at Publisher · View at Google Scholar · View at Scopus
  46. C. T. Weaver, R. D. Hatton, P. R. Mangan, and L. E. Harrington, “IL-17 family cytokines and the expanding diversity of effector T cell lineages,” Annual Review of Immunology, vol. 25, pp. 821–852, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. I. Böhm and R. Bauer, “Th1-cells, Th2-cells and atopic dermatitis,” Hautarzt, vol. 48, no. 4, pp. 223–227, 1997. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Romagnani, “Immunologic influences on allergy and the TH1/TH2 balance,” Journal of Allergy and Clinical Immunology, vol. 113, no. 3, pp. 395–400, 2004. View at Publisher · View at Google Scholar · View at Scopus
  49. A. P. Mountford, A. Fisher, and R. A. Wilson, “The profile of IgG1 and IgG2a antibody responses in mice exposed to Schistosoma mansoni,” Parasite Immunology, vol. 16, no. 10, pp. 521–527, 1994. View at Scopus
  50. C. S. Koblenzer, “Itching and the atopic skin,” Journal of Allergy and Clinical Immunology, vol. 104, no. 3, pp. S109–S113, 1999. View at Scopus
  51. C. F. Wahlgren, “Itch and atopic dermatitis: an overview,” Journal of Dermatology, vol. 26, no. 11, pp. 770–779, 1999. View at Scopus
  52. Q. Hamid, M. Boguniewicz, and D. Y. M. Leung, “Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis,” The Journal of Clinical Investigation, vol. 94, no. 2, pp. 870–876, 1994. View at Scopus
  53. A. B. Kay, S. Ying, V. Varney et al., “Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects,” Journal of Experimental Medicine, vol. 173, no. 3, pp. 775–778, 1991. View at Scopus
  54. Y. Tanaka, E. Delaporte, S. Dubucquoi et al., “Interleukin-5 messenger RNA and immunoreactive protein expression by activated eosinophils in lesional atopic dermatitis skin,” Journal of Investigative Dermatology, vol. 103, no. 4, pp. 589–592, 1994. View at Scopus
  55. S. Ying, D. S. Robinson, Q. Meng et al., “Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells,” European Journal of Immunology, vol. 27, no. 12, pp. 3507–3516, 1997. View at Publisher · View at Google Scholar · View at Scopus
  56. E. Bettelli, M. Oukka, and V. K. Kuchroo, “TH-17 cells in the circle of immunity and autoimmunity,” Nature Immunology, vol. 8, no. 4, pp. 345–350, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. L. Steinman, “A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell-mediated tissue damage,” Nature Medicine, vol. 13, no. 2, pp. 139–145, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. C. Koga, K. Kabashima, N. Shiraishi, M. Kobayashi, and Y. Tokura, “Possible pathogenic role of Th17 cells for atopic dermatitis,” Journal of Investigative Dermatology, vol. 128, no. 11, pp. 2625–2630, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. Y. Souwer, K. Szegedi, M. L. Kapsenberg, and E. C. De Jong, “IL-17 and IL-22 in atopic allergic disease,” Current Opinion in Immunology, vol. 22, no. 6, pp. 821–826, 2010. View at Publisher · View at Google Scholar · View at Scopus